Nutrition and exercise program for elderly colorectal cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates the impact of a mobile health intervention on frailty, physical fitness, physical activity, and nutritional status in elderly patients diagnosed with colorectal cancer. Participants will engage in the Mobile Health Management Frailty Care Program, which aims to enhance their overall well-being compared to standard care. The study seeks to determine if this program can effectively reduce frailty and improve physical health outcomes in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients diagnosed with colorectal cancer confirmed by a physician.
* Aged 60 and above.
* Have communication skills, able to read and write or converse in Mandarin and Taiwanese.
* Clear consciousness and no mental or cognitive impairment.
* Physical activities are accessible.
* Those who have a smartphone and have experience using smartphones.

Exclusion Criteria:

* People who have difficulty walking or standing.
* The wrist is not suitable for those wearing sports bracelets.
* People in infectious or protective isolation.
* Those who live alone or in institutions.

Where it's running

• Chang Gung Memorial Hospital
  Chiayi City, Taiwan Recruiting

Study contacts

• Principal investigator: Ching-Ching Su, PhD — Chang Gung University of Science and Technology
• Study coordinator: Ching-Ching Su, PhD
• Email: ccsu@mail.cgust.edu.tw
• Phone: 886+912649476

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Knife-assisted full-thickness resection for rectal lesions in a multicenter setting

  A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.

  Recruiting University Hospital, Ghent · Ghent · NCT07923682

• Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model

  This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.

  Recruiting Peking Union Medical College Hospital · Ningbo, Zhejiang · NCT07919418

• Integrated genomic and clinical database for cancer biomarker discovery

  Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.

  Recruiting Samsung Medical Center · Seoul, Gang-Nam · NCT07911267

• Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery

  Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.

  Recruiting Semmelweis University · Budapest · NCT07896174

• Liver transplantation for colorectal cancer with liver metastases

  This study follows adults with stage IV colorectal cancer whose disease is limited to the liver and who are getting a liver transplant as part of their cancer care to see how they fare over time.

  Recruiting Pontificia Universidad Catolica de Chile · Santiago, Santiago Metropolitan · NCT07884110

• LTZ-232: a first-in-human test in advanced colorectal and other solid tumors

  A first-in-human study tests LTZ-232, a new therapy for adults with unresectable or metastatic colorectal cancer and other solid tumors that have not responded to standard treatments.

  Recruiting Phase 1 LTZ Therapeutics, Inc. · Scottsdale, Arizona · NCT07878988

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.